Background The landscape of inflammatory bowel disease (IBD) treatment is rapidly
expanding with the development of new therapeutic options. Aim To review the mechanisms …

Ulcerative colitis (UC) is one of the two forms of inflammatory bowel disease. It affects 5
million people globally, and is a chronic and recurring inflammation of the gastrointestinal …

Intestinal fibrosis is one of the most threatening complications of Crohn's disease. It occurs in
more than a third of patients with this condition, is associated with increased morbidity and …

Artificial intelligence (AI) refers to computer-based methodologies which use data to teach a
computer to solve pre-defined tasks; these methods can be applied to identify patterns in …

TL1A, also called TNFSF15, is a member of tumor necrosis factor family. It is expressed in
different immune cell, such as monocyte, macrophage, dendritic cell, T cell and non-immune …

Ulcerative colitis (UC) is a chronic and progressive inflammatory disorder that affects the
colon. The advent of advanced therapies such as biologic agents and small molecules has …

Inflammatory bowel disease (IBD) is a term used to represent a group of chronic, relapsing
inflammatory disorders of the gastrointestinal tract. Crohn's disease (CD) and ulcerative …

Inflammatory bowel disease (IBD) is an immune-mediated chronic intestinal disorder with
major phenotypes: ulcerative colitis (UC) and Crohn's disease (CD). Multiple studies have …

Inflammatory bowel diseases (IBDs) are characterized by chronic inflammatory disorders
that are a result of an abnormal immune response mediated by a cytokine storm and …

Although the therapeutic armamentarium of Inflammatory bowel diseases (IBD) physicians
has expanded rapidly in recent years, a proportion of patients remain with a suboptimal …